A hypertensive patient is suffering from bilateral renal artery stenosis. Which of the following drug should not be given?
## **Core Concept**
Bilateral renal artery stenosis leads to decreased blood flow to both kidneys, activating the renin-angiotensin-aldosterone system (RAAS) and causing hypertension. The management of such patients requires careful consideration of the effects of antihypertensive drugs on renal function and the RAAS pathway.
## **Why the Correct Answer is Right**
The correct answer, **C. ACE inhibitors**, should not be given to patients with bilateral renal artery stenosis. ACE inhibitors block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release. In the setting of bilateral renal artery stenosis, the glomerular filtration rate (GFR) is maintained by the angiotensin II-mediated efferent arteriolar constriction. By inhibiting angiotensin II production, ACE inhibitors can reduce GFR, potentially leading to acute kidney injury or worsening renal function in these patients.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not specified, but generally, drugs that do not significantly affect the RAAS pathway or renal blood flow would be safer.
- **Option B:** This option is not specified, but typically, drugs that either do not affect or help in reducing blood pressure without severely impacting renal function in the context of renal artery stenosis could be considered.
- **Option D:** This option is not specified, but it could include drugs like calcium channel blockers or alpha-blockers that can help manage hypertension without directly impacting the RAAS system in a harmful way in the context of renal artery stenosis.
## **Clinical Pearl / High-Yield Fact**
In patients with bilateral renal artery stenosis or unilateral stenosis in a solitary functioning kidney, ACE inhibitors and angiotensin receptor blockers (ARBs) can lead to a decline in renal function and should be used with caution or avoided. These drugs are beneficial in patients with chronic kidney disease and proteinuria but require careful monitoring of renal function.
## **Correct Answer:** . ACE inhibitors